Literature DB >> 2460640

Minimum requirements for immunogenic and antigenic activities of homologs of a synthetic peptide of influenza virus hemagglutinin.

X L Tang1, G W Tregear, D O White, D C Jackson.   

Abstract

Synthetic peptides of increasing length and corresponding in sequence to the C-terminal end of the HA1 molecule of influenza virus were constructed and examined for their immunogenic and antigenic properties. Peptides containing at least the four C-terminal amino acids, when coupled to keyhole limpet hemocyanin, were capable of eliciting antibody in BALB/c mice that bound to the 24-residue parent peptide H3 HA1 (305 to 328). In the absence of a carrier, the C-terminal decapeptide was the shortest peptide capable of eliciting antibody. The specificity of this antibody was indistinguishable from that of a monoclonal antibody to the parent peptide which recognizes an epitope encompassed by the C-terminal seven residues. All peptides containing at least the C-terminal four residues were able to inhibit completely the binding of this monoclonal antibody to the parent peptide. Taken together, these results indicate that (i) the tetrapeptide is capable of eliciting specific antibody when coupled to a carrier, (ii) this tetrapeptide possesses all of the antigenic information necessary to occupy the paratope of a monoclonal antibody elicited by the longer parent peptide, and (iii) the decapeptide contains all of the information necessary to elicit a specific immune response and therefore carries an epitope recognized by T cells as well as one recognized by B cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460640      PMCID: PMC253590     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  8 in total

1.  Antigenic determinants of influenza virus hemagglutinin. XII. the epitopes of a synthetic peptide representing the C-terminus of HA1.

Authors:  D C Jackson; X L Tang; L E Brown; J M Murray; D O White; G W Tregear
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

2.  Synthetic peptides as antigens: pitfalls of conjugation methods.

Authors:  J P Briand; S Muller; M H Van Regenmortel
Journal:  J Immunol Methods       Date:  1985-04-08       Impact factor: 2.303

3.  Epitopes of an influenza viral peptide recognized by antibody at single amino acid resolution.

Authors:  P G Schoofs; H M Geysen; D C Jackson; L E Brown; X L Tang; D O White
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

4.  Antibodies elicited by influenza virus hemagglutinin fail to bind to synthetic peptides representing putative antigenic sites.

Authors:  A Nestorowicz; G W Tregear; C N Southwell; J Martyn; J M Murray; D O White; D C Jackson
Journal:  Mol Immunol       Date:  1985-02       Impact factor: 4.407

5.  Simultaneous binding of two monoclonal antibodies to epitopes separated in sequence by only three amino acid residues.

Authors:  D C Jackson; P Poumbourios; D O White
Journal:  Mol Immunol       Date:  1988-05       Impact factor: 4.407

6.  Analysis of the antigen specificity of influenza haemagglutinin-immune human T lymphocyte clones: identification of an immunodominant region for T cells.

Authors:  J R Lamb; N Green
Journal:  Immunology       Date:  1983-12       Impact factor: 7.397

7.  Genetic control and fine specificity of the immune response to a synthetic peptide of influenza virus hemagglutinin.

Authors:  L E Brown; J M Murray; E M Anders; X L Tang; D O White; G W Tregear; D C Jackson
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

8.  A sequence pattern common to T cell epitopes.

Authors:  J B Rothbard; W R Taylor
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

  8 in total
  7 in total

1.  Class II-restricted T-cell clones to a synthetic peptide of influenza virus hemagglutinin differ in their fine specificities and in the ability to respond to virus.

Authors:  R A Ffrench; X L Tang; E M Anders; D C Jackson; D O White; H Drummer; J D Wade; G W Tregear; L E Brown
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

2.  Electron microscopic evidence for the association of M2 protein with the influenza virion.

Authors:  D C Jackson; X L Tang; K G Murti; R G Webster; G W Tregear; W J Bean
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses.

Authors:  L E Brown; D O White; C Agius; B E Kemp; N Yatzakis; P Poumbourios; D A McPhee; D C Jackson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

4.  Identification of a highly conserved H1 subtype-specific epitope with diagnostic potential in the hemagglutinin protein of influenza A virus.

Authors:  Rongmao Zhao; Shujuan Cui; Li Guo; Chao Wu; Richard Gonzalez; Gláucia Paranhos-Baccalà; Guy Vernet; Jianwei Wang; Tao Hung
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

5.  Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.

Authors:  Miriam Klausberger; Rupert Tscheliessnig; Silke Neff; Raffael Nachbagauer; Teddy John Wohlbold; Monika Wilde; Dieter Palmberger; Florian Krammer; Alois Jungbauer; Reingard Grabherr
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

6.  Localization of the virus neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus.

Authors:  H Chaye; P Chong; B Tripet; B Brush; S Gillam
Journal:  Virology       Date:  1992-08       Impact factor: 3.616

7.  Masking terminal neo-epitopes of linear peptides through glycosylation favours immune responses towards core epitopes producing parental protein bound antibodies.

Authors:  Robert Pon; Anne Marcil; Wangxue Chen; Christine Gadoury; Dean Williams; Kenneth Chan; Hongyan Zhou; Amalia Ponce; Eric Paquet; Komal Gurnani; Anindita Chattopadhyay; Wei Zou
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.